Abstracts tagged "Epidemiologic methods"

Abstract Number: 2015 • 2014 ACR/ARHP Annual Meeting
Fine Particulate Air Pollution and Systemic Autoimmune Rheumatic Disease in Two Canadian Provinces
Sasha Bernatsky¹, Audrey Smargiassi², Cheryl Barnabe³, Lawrence W. Svenson⁴, Allan Brand⁵, Marie Hudson⁶, Steven M. Edworthy⁷, Ann E. Clarke³, Paul R. Fortin⁸, Patrick Belisle⁹ and Lawrence Joseph¹⁰, ¹Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ²Département de santé environnementale et santé au travail, Université de Montréal, Montréal, QC, Canada, ³Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ⁴Community Health Sciences, University of Calgary, Calgary, AB, Canada, ⁵Institut national de santé publique du Québec, Montreal, QC, Canada, ⁶Rheumatology, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, ⁷The University of Calgary, Calgary, AB, Canada, ⁸Rheumatology, Laval University, Division of Rheumatology, Centre de Recherche du CHU de Québec and Department of Medicine, Quebec City, QC, Canada, ⁹Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ¹⁰McGill University, Montreal, QC, Canada
Background/Purpose: To estimate the degree to which fine particulate (PM2.5) air pollution is associated with systemic autoimmune rheumatic diseases (SARDs). Methods: We used population-based administrative…
Abstract Number: 59 • 2014 ACR/ARHP Annual Meeting
Assessing Dietary Habits in a Large Cohort of Rheumatoid Arthritis and Psoriatic Arthritis Patients: Results of the Spanish Imid Consortium
Maria López Lasanta¹, Jesús Tornero², Juan D. Cañete³, Antonio Fernandez Nebro⁴, Francisco Blanco⁵, Jesus Rodriguez⁶, Isidoro González-Alvaro⁷, Jordi Gratacós⁸, Joan Maymo⁹, Rubén Queiro¹⁰, Mercedes Alperi-López¹¹, Carlos Montilla-Morales¹², Benjamin Fernandez Gutierrez¹³, Juan Carlos Torre-Alonso¹⁴, Alejandro Olive¹⁵, Jose Javier Perez Venegas¹⁶, Hector Corominas¹⁷, Alba Erra¹⁸, Santiago Muñoz¹⁹, Carlos M. Gonzalez²⁰, Daniel Roig²¹, Gabriela Avila¹, Arnald Alonso¹, Toni Julia¹, Raül Tortosa¹, Andrés Garcia Montero²² and Sara Marsal¹, ¹Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, ²Hospital Universitario Guadalajara, Guadalajara, Spain, ³Arthritis Unit. Rheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain, ⁴Rheumatology, Hospital Regional Carlos Haya, Biomedical Research Institute of Malaga (IBIMA), Malaga, Spain, ⁵Complejo Hospitalario Juan Canalejo, A Coruña, Spain, ⁶Rheumatology, Hospital Universitari de Bellvitge, Barcelona, Spain, ⁷Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, ⁸Hospital Parc Taulí, Sabadell, Spain, ⁹Rheumatology, Hospital del Mar, Barcelona, Spain, ¹⁰Rheumatology Department. Hospital Universitario Central de Asturias, Oviedo, Spain, ¹¹Rheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain, ¹²H. de Salamanca, Salamanca, Spain, ¹³Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ¹⁴Rheumatology Department, H. Monte Naranco, Oviedo, Spain, ¹⁵Rheumatology Service, Germans Trias Pujol Hospital, Barcelona, Spain, ¹⁶Rheumatology Department, Hospital del SAS Jerez de la Frontera, Cadiz, Spain, ¹⁷Rheumatology, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain, ¹⁸Rheumatology Department, Hospital Sant Rafael, Barcelona, Spain, ¹⁹Rheumatology Department, Hospital Infanta Sofia, Madrid, Spain, ²⁰Rheumatology Department, Gregorio Marañon Hospital, Madrid, Spain, ²¹Rheumatology Service, Hospital Moisès Broggi,, Barcelona, Spain, ²²Banco Nacional de ADN, Salamanca, Spain
Background/Purpose: Rheumatoid arthritis (RA) and Psoriatic arthritis (PsA) are complex diseases of unknown etiology and its pathogenesis results from the combination of genetic susceptibility and…
Abstract Number: 1235 • 2013 ACR/ARHP Annual Meeting
Predictors Of Fracture In Patients With Osteopenia: Data From An Observational Cohort
Kathryn Mitchell¹, Peter Diggle¹ and Marwan Bukhari^1,2, ¹Faculty of Health and Medicine, Lancaster, United Kingdom, ²Department of Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom
Background/Purpose: The risk factors for osteoporotic fragility fractures are well documented in the literature and although they are associated with a diagnosis of established osteoporosis…
Abstract Number: 262 • 2013 ACR/ARHP Annual Meeting
Is There a Role For Non-Mendelian Inheritance In Severe Osteoarthritis Of The Knee
Allen D. Sawitzke¹, Richard Pimentel², Jathine Wong², Helena Martinez³, Marta Herrero³, Josep Verges⁴ and Daniel O. Clegg⁵, ¹Rheumatology, University of Utah, Salt Lake City, UT, ²University of Utah, Salt Lake, UT, ³Pharmascience Division, Bioiberica S.A., Barcelona, Spain, ⁴Pharmacological Research Unit, Scientific Medical Department, Bioibérica, S.A., Barcelona, Spain, ⁵Rheumatology, George Wahlen VA Medical Center/University of Utah, Salt Lake City, UT
Background/Purpose: Although the etiopathogenesis of osteoarthritis of the knee remains largely unknown, it is clear that genetic risks are contributory. Traditional family, twin, case control…
Abstract Number: 137 • 2013 ACR/ARHP Annual Meeting
A Population-Based Survey and Physician Assessment Of The Characteristics and Prevalence Of Fibromyalgia
Edgar H. Adams¹, Shoshana Daniel², Arthi B. Chandran³, Heather McElroy⁴, Caroline Schaefer¹, Rachael Mann⁵, Gergana Zlateva³, Joseph C. Cappelleri⁶, Elizabeth T. Masters⁷, Annlouise R. Assaf⁶, Michael McNett⁸, Stuart L. Silverman⁹, Roland Staud¹⁰ and Philip Mease¹¹, ¹Covance Market Access Services Inc., Gaithersburg, MD, ²Covance Market Access Services Inc., Conshohocken, PA, ³Pfizer Inc., New York, NY, ⁴Covance Market Access Services, Sydney, Australia, ⁵Covance Market Access Services Inc., San Diego, CA, ⁶Pfizer Inc., Groton, CT, ⁷Pfizer Inc, New York, NY, ⁸Aurora Pain Program, Milwaukee, WI, ⁹Cedars-Sinai Medical Center, UCLA Center of Excellence, Los Angeles, CA, ¹⁰Dept Med/Rheum/Clin Immun Div, University of Florida, Gainesville, FL, ¹¹Director, Rheumatology Research, Swedish Medical Center, Seattle, WA
Background/Purpose: No large-scale, national study estimating fibromyalgia (FM) prevalence in the United States (US) has been conducted involving physician evaluation. The study objective was to…
Abstract Number: 1220 • 2013 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Characteristics and Fracture Risk: A Population-Based Study
Shreyasee Amin¹, Sherine E. Gabriel², Sara J. Achenbach³, Elizabeth J. Atkinson³, Terry M. Therneau³ and L. Joseph Melton III³, ¹Division of Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN, ³Department of Health Sciences Research, Mayo Clinic, Rochester, MN
Background/Purpose: Women and men with rheumatoid arthritis [RA] are at increased risk for a fragility fracture [fx]. To help better target those in need of…
Abstract Number: 243 • 2013 ACR/ARHP Annual Meeting
The Association Between Metabolic Syndrome and Hand Osteoarthritis – Data From The Framingham Study
Ida K. Haugen¹, Vasan Ramachandran^2,3, Devyani Misra⁴, Tuhina Neogi⁴, Jingbo Niu⁴, Yuqing Zhang⁵ and David T. Felson⁵, ¹Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, MA, ³Cardiology, Boston University School of Medicine, Boston, MA, ⁴Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ⁵Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA
Background/Purpose: Metabolic factors may have a negative effect on cartilage, and may be especially relevant in the pathogenesis of hand OA. Our aim was to…
Abstract Number: 2829 • 2013 ACR/ARHP Annual Meeting
Statin Adherence and Risk Of Mortality In Patients With Rheumatoid Arthritis: A Population-Based Study
Mary De Vera^1,2, Michal Abrahamowicz³ and Diane Lacaille⁴, ¹Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ²Arthritis Research Centre of Canada, Richmond, BC, Canada, ³Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, ⁴Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada
Background/Purpose: Poor adherence with statin therapy is associated with increased mortality in the general population, but no corresponding data are available among patients with rheumatoid…
Abstract Number: 1209 • 2013 ACR/ARHP Annual Meeting
Starting Time Of Inflammatory Attacks In Patients With Familial Mediterranean Fever
Feyza Berktas¹, Nilufer Alpay Kanitez¹, Bahtiyar Toz¹, Oguz Kaan Bakkaloglu¹, Burak Erer² and Ahmet Gul¹, ¹Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ²Department of Internal Medicine, Rheumatology Division, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
Background/Purpose: Familial Mediterranean fever (FMF), the most common form of the hereditary autoinflammatory diseases, is characterized by recurrent self-limiting attacks of fever and/or serositis accompanied…
Abstract Number: 96 • 2013 ACR/ARHP Annual Meeting
Epidemiology and Health Services Use For Osteoarthritis By First Nations People In Alberta, Canada
Cheryl Barnabe¹, Allyson Jones², Ed Enns³, Don Voaklander⁴, Christine Peschken⁵, Joanne Homik⁴, John Esdaile⁶, Sasha Bernatsky⁷, Brenda Hemmelgarn⁸ and Deborah Marshall⁹, ¹Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, ²Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, ³Alberta Bone and Joint Health Institute, Calgary, AB, Canada, ⁴University of Alberta, Edmonton, AB, Canada, ⁵Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, ⁶Medicine, University of British Columbia, Vancouver, BC, Canada, ⁷Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, ⁸Division of Nephrology, University of Calgary, Calgary, AB, Canada, ⁹University of Calgary, Calgary, AB, Canada
Background/Purpose: Self-reported survey data and a single provincial administrative data source have previously indicated that the First Nations (FN) population in Canada has a 1.5…
Abstract Number: 2759 • 2013 ACR/ARHP Annual Meeting
Can RA Registries Provide Contextual Safety Data For Modern RCTs?
Kaleb Michaud¹, Johan Askling², Hisashi Yamanaka³, Deborah Symmons⁴, Marie Holmqvist², Thomas Frisell⁵, George Reed⁶, Dimitrios A. Pappas⁷, Eiichi Tanaka⁸, Eisuke Inoue⁹, Suzanne M.M. Verstappen⁴, Christopher Garwood⁴, Laura Horne¹⁰, Kathy Lampl¹¹, Niklas Berglind¹², Stefan Franzen¹², Fredrik Nyberg¹³, Trung Tran¹⁴, Meilien Ho¹⁵ and Jeffrey D. Greenberg¹⁶, ¹Rheumatology, National Data Bank for Rheumatic Diseases & University of Nebraska Medical Center, Omaha, NE, ²Karolinska Institutet, Stockholm, Sweden, ³Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ⁴Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, ⁵Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, ⁶Orthopedics, University of Massachusetts Medical School, Worcester, MA, ⁷Columbia University, New York, NY, ⁸Tokyo Women's Medical University, Tokyo, Japan, ⁹Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, ¹⁰AstraZeneca, Wilmington, DE, ¹¹AstraZeneca R&D Wilmington, Wilmington, DE, ¹²AstraZeneca R&D Mölndal, Mölndal, Sweden, ¹³AstraZeneca R&D, Mölndal, Sweden, ¹⁴MedImmune LLC, Gaithersburg, MD, ¹⁵AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, ¹⁶New York University School of Medicine, New York, NY
Background/Purpose: For ethical reasons, modern phase-III RCTs in rheumatoid arthritis (RA) have limited placebo exposure time, resulting in uncertainties when interpreting low frequency adverse events…
Abstract Number: 1052 • 2013 ACR/ARHP Annual Meeting
Glucocorticosteroids and Mortality Risk In Rheumatoid Arthritis – Results Of a Population Based Study
Diane Lacaille¹, J. Antonio Avina-Zubieta^2,3, Eric C. Sayre², Michal Abrahamowicz⁴ and John Esdaile^1,5, ¹Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, ²Arthritis Research Centre of Canada, Richmond, BC, Canada, ³Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, ⁵Medicine, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Glucocorticosteroids (GC) are frequently used in the management of rheumatoid arthritis (RA). Due to their metabolic and immunosuppressive effects, they could increase the risk…
Abstract Number: 2682 • 2013 ACR/ARHP Annual Meeting
Incidence Trends and Predictors Of Orthopedic Surgery In Patients With Rheumatoid Arthritis – Results From a Well Defined Population
Korosh Hekmat¹, Lennart Jacobsson², Jan-Åke Nilsson³, Minna Willim⁴, Martin Englund⁵, Ingemar F. Petersson⁶ and Carl Turesson², ¹Department of Clinical Sciences, Section of Rheumatology, Malmö, Lund University, Malmö, Sweden, ²Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, ³Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, ⁴Department of Clinical Sciences Malmö, Section of Rheumatology, Lund University, Malmö, Sweden, ⁵Department of Orthopedics, Clinical Sciences Lund,, Lund University, Lund, Sweden, ⁶Musculoskeletal Scienes, Department of Orthopedics, Clinical Sciences, Lund, Sweden
Background/Purpose: Orthopedic surgery is used effectively in many patients with severe rheumatoid arthritis (RA). The aim of modern pharmacologic treatment is to prevent joint destruction…
Abstract Number: 1067 • 2013 ACR/ARHP Annual Meeting
Incidence and Prevalence Of Systemic Lupus Erythematosus: A 2010 Nation-Wide Population-Based Study Using French National Administrative Databases
Laurent Arnaud¹, Jean-Paul Fagot², Michel Païta², Alexis Mathian³, Anne Fagot-Campagna² and Zahir Amoura⁴, ¹Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, ²Caisse Nationale d’Assurance Maladie des Travailleurs Salariés, Paris, France, ³Internal Medicine Dpt 2, Pitié-Salpêtrière Hospital, APHP, Paris, France, ⁴Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France
Background/Purpose: To date, only a small number of studies have examined the epidemiology of systemic lupus erythematosus (SLE) on a nation-wide basis. These studies were…
Abstract Number: 2661 • 2013 ACR/ARHP Annual Meeting
Physical Activity, Adiposity, and The Risk Of Gout In Women: The Nurses Health Study
Hyon Choi^1,2,3, Lindsay C Burns^4,5, Yuqing Zhang⁶, Sharan Rai¹ and Gary Curhan⁷, ¹Arthritis Research Centre of Canada, Richmond, BC, Canada, ²Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ³Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁴Research, Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁵Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada, ⁶Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁷German Research Center for Environmental Health, Harvard Medical School, Boston, MA
Background/Purpose: There is a remarkable, increasing disease burden of gout and its associated cardiovascular (CV)-metabolic comorbidities in the US. While the benefits of physical exercise…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].